Furthermore, naringenin interferes with A plaque formation by regulating amyloid precursor protein (APP) processing, reducing A production, and preventing tau hyperphosphorylation, thereby safeguarding neurons from aggregationinduced toxicity (D'Egidio et al
New forms, like liposomal glutathione, solve this problem, but it is still important to consume a nutrient rich diet that includes the building blocks of glutathione (especially from leafy greens and onions/garlic)
FIGURE 1 3 Immunomodulatory and anti-inflammatory effects of PYC The immunomodulatory effects of PYC have been demonstrated extensively ( in vitro study, Moreover, the toll-like receptor (TLR)-mediated immunomodulatory effects of PYC have been investigated ( In an in vitro study on microglial cells, PYC dose-dependently decreased the release of nitric oxide, tumor necrosis factor- (TNF-), interleukin (IL)-6, IL-1, ICAM-1, and perilipin 2, thereby exhibiting anti-inflammatory activity ( Ex vivo analysis of plasma from volunteers following PYC administration revealed moderate inhibition of COX-1 and COX-2 activity, indicating potential anti-inflammatory and platelet-inhibitory effects ( PYC modulated cytokine secretion by decreasing in T-helper (Th)1 cytokine levels and increasing Th2 cytokine levels and partially recovered T- and B-cell dysfunction in a mouse model ( In a murine model, PYC demonstrated neuroprotective effects following traumatic brain injury, characterized by a reduction in the proinflammatory cytokines IL-6 and TNF- ( Collectively, these reports reveal the potent anti-inflammatory and immunomodulatory effects of PYC (Figure 1), warranting further clinical trials to evaluate its therapeutic efficacy against various infections, including viral infections that induce host inflammation and immune dysregulation
A Herxheimer reaction can temporarily intensify symptoms such as fatigue, pain, brain fog, dizziness, or flu-like illness after treatment begins
The system rapidly identified formulations that met multiple requirements (particle size, stability, drug loading, and release profile), thus accelerate the transition from screening to optimization [198]
